Currently, the LH-RH analogs used clinically for the therapy of advanced prostate cancer include triptorelin (Decapeptyl, Trelstar)14, Leuprolide (Lupron, Eligard), buserelin (Suprefact, Suprecur) and goserelin (Zoladex). The gene discussed is GNRH1; the disease is Familial prostate cancer.